Related Articles
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)
HSP90 and its inhibitors (Review)
Tumor immunotherapy based on tumor‑derived heat shock proteins (Review)
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
HSP70 inhibits high glucose-induced Smad3 activation and attenuates epithelial-to-mesenchymal transition of peritoneal mesothelial cells